Neuroscience
| 2 min read
Shimadzu Scientific Instruments has taken the wraps off several new products,
including AXIMA MegaTOF, an integrated MALDI solution from Shimadzu and CovalX for ultra high-mass applications that detect intact complexes up to 1.5 MDa.;
Nexera Ultra High-Performance Liquid Chromatograph, which meets all analysis requirements with no compromise in data integrity; Nanotrap Biomarker Discovery
Platform, which gives researchers the ability to enrich, preserve and screen low-level biomarkers directly from complex biological samples; and Component ID
Solution, software that accelerates high-confidence component identification using the power of high-mass accuracy and the simplicity of an open-access
workflow.
| 2 min read
Thermo Scientific
Nautilus LIMS enhances workflow and fosters collaboration between Emory University and external consortia
| 3 min read
Freeslate announces software partnership with Johnson & Johnson Pharmaceutical Research &
Development
| 4 min read
Researchers show a direct cellular interaction between the endocannabinoid system and
alcohol in the brain, and find that that the endocannabinoid system may actually be able dampen the effects of alcohol as well
| 2 min read
The discoveries, technologies and advances involved in
the deals our editors and reporters write about each month sometimes hit very close to home.
| 4 min read
Rett
Syndrome Research Trust, Melior Discovery to develop drug candidates for most disabling form of autism
| 1 min read
OpenHelix to provide training and outreach programs for PDB's resources
| 2 min read
David H.
Murdock Research Institute partners with ArtusLabs for cross-disciplinary electronic lab notebook
| 1 min read
BioTek Instruments Inc. has expanded its Synergy Multi-Mode Microplate Reader family with the introduction of the patent-pending Synergy H4 with Hybrid Technology.
| 2 min read
Acquisition of Protein Forest gives Cell Biosciences extra proteomic muscle
| 4 min read
A recent study published by researchers at Stanford University School of Medicine and Lucile Packard Children’s Hospital describes how boosting norepinephrine (NE) signaling in the brains of mice genetically engineered to mimic Down syndrome may improve the cognitive development of individuals with the genetic disorder. According to the researchers, the finding could introduce the possibility of developing drugs that enhance NE signaling, giving the Down syndrome community hope for a way to help children with Down’s collect and modulate information.
| 4 min read
An international team of researchers has found that people who carry the gene for a rare genetic problem known as Gaucher disease have at least five times the normal risk of developing Parkinson’s disease. The finding suggests that the gene is one cause of the disease, but indicates that other factors must be operating as well, because not all patients who have Gaucher also develop Parkinson’s.
